Compare Charles River Laboratories Intl. Inc (CRL) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Keysight Technologies Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $302.01 (market cap $14.23B), while Keysight Technologies Inc trades at $377.13 (market cap $63.79B). The key difference: Keysight Technologies Inc is far larger — about 4.5× Charles River Laboratories Intl. Inc's market cap, and Keysight Technologies Inc is more actively traded (1,435,384 versus 1,176,885). Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Keysight Technologies Inc for 56 Days on average.
| CRL | KEYS | |
|---|---|---|
Market Cap | $14.23B | $63.79B |
Volume | 1,176,885 | 1,435,384 |
Sector | Health | Technology |
52-Week High | $310.77 | $387.90 |
52-Week Low | $149.93 | $159.49 |
Typical Hold Time | 33 Days | 56 Days |
Enterprise Value | $17.06B | $63.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
KEYS trades at $381.49, down 1.65% on the day, with a bullish technical signal from moving averages and strong fundamental performance including three consecutive quarterly earnings beats. Revenue for 2025 reached $5.38 billion with a net income margin of 19.14%, while analyst consensus is strongly bullish with an 81.25% buy rating and a $416.63 price target. Recent news highlights growth in AI infrastructure and 6G technology development.
The outlook for KEYS is positive, driven by accelerating earnings and expanding AI and 6G opportunities, though high valuation multiples and supply chain constraints present risks. Upside potential exists if the company continues to exceed earnings expectations and capitalize on tech sector demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
